The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples
Read Press ReleaseOliLux Biosciences will expand its research and clinical operations to develop diagnostic and treatment monitoring tools for the rapid detection and management of tuberculosis.
Read Press ReleaseHEMA DIAGNOSTIC SYSTEMS announces the execution of a non-binding letter of intent with Generex Biotechnology Corporation. HDS and Generex will work together to bring technologies developed by both companies together by incorporating the new and novel rapid diagnostic test systems for worldwide market expansion.
Read Press ReleaseA new book entitled Autism: An Ancient Foe Becomes a Modern Scourge -the return of a stealth bacteria, by Lawrence Broxmeyer, M.D. makes a well-documented case for the fact that a stealth pathogen, eluding today's diagnostics , is behind autism.
Read Press ReleaseRegulatory Officials disclosed to Compliance Officials at Knight Investments LLC that the age old disease of Leprosy was making cases in the United States; informing how KI compliance could help.
Read Press ReleaseMassachusetts General Hospital announcement of human trials with dilute cow tuberculosis (BCG) to attempt cure of type 1 juvenile diabetes predicted by physician/researcher Broxmeyer a decade ago.
Read Press ReleaseRecently, we interviewed Pennsylvania internist Dr. Lawrence Broxmeyer, who's book Parkinsons- Another Look documents evidence that Parkinson's Disease is of bacterial cause.
Read Press ReleaseAlthough Mad cow disease hasn't been in the news these days, it hasn't disappeared. As with its counterpart, Creutzfeldt-Jakob in humans, it's still a force to be reckoned with, says Lawrence Broxmeyer MD.
Read Press Release